EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System

Arnold R Gammaitoni, Martha J Morrell, Jacqueline A French, Daniel Friedman, Kathryn A Davis, Thomas K Tcheng, Cairn G Seale, Miganush Stepanians, Bradley S Galer, William W Motley

Epilepsy & Behavior · 2026

DOI: 10.1016/j.yebeh.2026.111248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026. Verfasst von Arnold R Gammaitoni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rapport Therapeutics, Inc., Boston, MA, USA. Electronic address: gammaitoni2013@verizon.net. Hauptthemen laut MEDLINE: Anticonvulsants, Electrocorticography, Drug Resistant Epilepsy, Epilepsy. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Novel proof-of-concept designs utilizing biomarkers associated with an established clinically meaningful outcome are needed for antiseizure medication (ASM) efficacy assessment in patients with epilepsy, including drug-resistant focal epilepsy. Changes in long episode (LE) frequency, recorded by the responsive neurostimulator (RNS® System), are associated with changes in clinical seizure (CS) frequency following ASM initiation, suggesting that LEs may serve as a valid biomarker. Here, we aimed to establish the LE reduction magnitude associated with a clinically meaningful CS reduction. METHODS: Post hoc retrospective analyses of CS and LE frequencies, responder rate, and receiver operating characteristics from a long-term RNS open-label treatment study in patients who met predefined criteria were performed to evaluate the association between changes in LE and CS frequency and the LE reduction cutpoint associated with a ≥ 50% CS reduction. RESULTS: Patients (N=45) initiated clobazam (n=15), levetiracetam (n=4), or lacosamide (n=26). Patients achieved a median 30% LE and 50% CS reduction. Patients with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsElectrocorticographyDrug Resistant EpilepsyEpilepsyImplantable NeurostimulatorsHumansFemaleMaleRetrospective StudiesAdultTreatment OutcomeMiddle AgedLevetiracetamClobazamLongitudinal StudiesLacosamideYoung AdultElectroencephalographySeizuresEpilepsies, Partial

Stichwörter der Autor:innen

BiomarkerFocal onset seizuresPhase 2Proof-of-concept studyResponsive neurostimulator

Substanzen

AnticonvulsantsLevetiracetamClobazamLacosamide

Autor:innen und Institutionen

  • Rapport Therapeutics, Inc., Boston, MA, USA. Electronic address: gammaitoni2013@verizon.net.
  • NeuroPace, Inc., Mountain View, CA, USA.
  • Comprehensive Epilepsy Center, Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA.
  • Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA, USA.
  • PROMETRIKA, LLC, Cambridge, MA, USA.
  • Mosaica Medicines, Boston, MA, USA.

Zitieren

APA

Gammaitoni, A. R., Morrell, M. J., French, J. A., Friedman, D., Davis, K. A., Tcheng, T. K., Seale, C. G., Stepanians, M., Galer, B. S., & Motley, W. W. (2026). Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2026.111248

Vancouver

Gammaitoni AR, Morrell MJ, French JA, Friedman D, Davis KA, Tcheng TK, et al. Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System. Epilepsy & Behavior. 2026. doi:10.1016/j.yebeh.2026.111248

BibTeX
@article{Gammaitoni2026,
  author = {Gammaitoni, Arnold R and Morrell, Martha J and French, Jacqueline A and Friedman, Daniel and Davis, Kathryn A and Tcheng, Thomas K and Seale, Cairn G and Stepanians, Miganush and Galer, Bradley S and Motley, William W},
  title = {Exploratory definition of a clinically meaningful change in intracranial EEG features: Analysis of data from a long-term treatment study of the RNS® System},
  journal = {Epilepsy & Behavior},
  year = {2026},
  doi = {10.1016/j.yebeh.2026.111248}
}
Kostenlos starten →